Show
Sort by
-
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
-
- Journal Article
- A1
- open access
Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population
-
Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma
-
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
-
- Conference Paper
- C3
- open access
The prevalence of sensitization and relevant symptoms of allergic rhinitis in an unselected Belgium population
-
Mepolizumab, a humanised anti-IL-5 monoclonal antibody, as treatment of severe nasal polyposis